Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16

Author: Benzinga Newsdesk | November 07, 2023 11:10am
Stifel analyst Stephen Manaker maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raises the price target from $14 to $16.

Posted In: SBRA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist